Hyperactive chemotaxis contributes to anti-TNFα treatment resistance in inflammatory bowel disease
Tung On Yau, Jayakumar Narayanan Vadakekolathu, Gemma Ann Foulds, Guodong Du, Christos Polytarchou, Benjamin Dickins, Sergio Rutella
The paper identifies hyperactive chemotaxis and IL13RA2 as factors contributing to anti-TNFα treatment resistance in IBD.
Journal of Gastroenterology and Hepatology · Dec 20, 2021Peer-reviewedMolecular Biology